Key Takeaway
About the difference between CJC-1295 DAC vs no DAC is important before starting GH peptide therapy. Both versions stimulate growth hormone release, but their pharmacokinetics differ dramatically.
About the difference between CJC-1295 DAC vs no DAC is important before starting GH peptide therapy. Both versions stimulate growth hormone release, but their pharmacokinetics differ dramatically. This affects how often you inject, what your GH release pattern looks like, and which is better suited to your goals.
Key Takeaways: - The Key Difference: Half-Life - Pros and Cons of Each Version - Dosing Protocols Compared - Which Version Is Right for You
This guide breaks down the science, dosing, and practical differences so you can have an informed conversation with your provider.
The Key Difference: Half-Life
The Drug Affinity Complex (DAC) is a modification that extends how long CJC-1295 stays active in your body. This single change creates two fundamentally different peptides.
CJC-1295 with DAC: - Half-life: 6-8 days - The DAC modification allows the peptide to bind to albumin in your blood, dramatically extending its duration - Creates sustained, improved GHRH signaling over days - Results in a constant GH elevation rather than pulsatile release - Requires less frequent injections (1-2 times per week)
CJC-1295 without DAC (Mod GRF 1-29): - Half-life: approximately 30 minutes - Rapidly absorbed and cleared from the body - Creates sharp GH pulses that mimic natural physiology - GH levels rise and fall naturally between doses - Requires more frequent injections (1-3 times daily)
"The key to successful GLP-1 therapy is setting realistic expectations and supporting patients through the titration phase. The side effects are manageable for most people, but they need to know what to expect.") Dr. Caroline Apovian, MD, Harvard Medical School
The natural pattern of GH release is pulsatile. Your pituitary gland releases GH in bursts throughout the day, with the largest surge occurring during deep sleep. The no-DAC version preserves this pattern. The DAC version overrides it with sustained elevation.
Most providers who specialize in peptide therapy prefer the no-DAC version because it more closely mimics natural physiology. But both have valid uses.
Learn about for the gold standard stack.
Pros and Cons of Each Version
CJC-1295 WITH DAC (Pros: - Convenient: inject only 1-2 times per week - Consistent GH elevation without daily dosing - Simpler protocol for busy lifestyles - Sustained IGF-1 elevation
Free Download: Protocol Planner Compare DAC and no-DAC protocols side by side with dosing schedules and expected outcomes. Get yours free) we'll email it to you instantly. [Download Your Free Protocol Planner]
CJC-1295 WITH DAC (Cons: - Non-physiological GH release pattern (sustained vs pulsatile) - May cause more side effects due to constant GH elevation - Higher risk of GH-related water retention and joint issues - Potentially suppresses natural GH pulsatility - Less studied in clinical settings than the non-DAC version
CJC-1295 WITHOUT DAC) Pros: - Mimics natural pulsatile GH release - Lower risk of GH-related side effects - Better pairing with Ipamorelin for combined pulses - More physiological approach to GH improvement - Preferred by most peptide specialists
CJC-1295 WITHOUT DAC (Cons: - Requires daily injection (1-3 times per day) - Must be timed around meals (fasting required) - More complex protocol management - Higher injection volume over time
The trend in clinical practice has moved toward the no-DAC version combined with Ipamorelin as the preferred approach. The more natural GH release pattern is considered safer for long-term use.
Dosing Protocols Compared
Here is how typical protocols differ between the two versions.
From the FormBlends catalog
CJC-1295 DAC
Long-acting GHRH analog with Drug Affinity Complex for sustained GH elevation · From $42/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about CJC-1295 DAC →CJC-1295 WITH DAC protocol: - Dose: 2mg per injection - Frequency: once or twice per week - Often combined with daily Ipamorelin (100-200mcg at bedtime) - Protocol duration: 8-16 weeks - Cycling: 3 months on, 1 month off
CJC-1295 WITHOUT DAC protocol: - Dose: 100mcg per injection - Frequency: 1-3 times daily - Combined with Ipamorelin (100-200mcg) at each injection - Protocol duration: 8-16 weeks - Cycling: 3 months on, 1 month off
Most common practical approach: 100mcg CJC-1295 (no DAC) + 200mcg Ipamorelin injected subcutaneously at bedtime on an empty stomach. This single daily injection is sufficient for most anti-aging and recovery goals.
Use the to prepare either version correctly.
Track your protocol in the for consistent dosing and progress monitoring.
Which Version Is Right for You?
Your choice depends on your goals, lifestyle, and tolerance for injection frequency.
Choose no-DAC if: - You prioritize natural, physiological GH patterns - You're comfortable with daily injections - You want to combine with Ipamorelin for maximum combined effect - Long-term use is your plan - Your provider specializes in peptide therapy
Choose with-DAC if: - Injection frequency is a major concern - You travel frequently and need a simpler schedule - You have tried daily protocols and compliance was an issue - Your provider recommends it based on your specific situation
Most provider recommendations: The majority of providers who specialize in peptide improvement recommend CJC-1295 without DAC (Mod GRF 1-29) combined with Ipamorelin. This combination has become the standard of care in the peptide therapy space.
Your can evaluate your goals, lifestyle, and health profile to recommend the right version for you.
Frequently Asked Questions
Can I switch from DAC to no-DAC mid-protocol?
Yes. There's no safety concern with switching between versions. Allow a washout period of about one week after your last DAC injection before starting the no-DAC protocol to avoid overlapping effects.
Will the DAC version keep me improved all week?
The DAC version maintains improved GHRH signaling for 6-8 days. This produces more sustained GH elevation compared to the sharp pulses from the no-DAC version. Some practitioners consider this less desirable because the body naturally releases GH in pulses.
Is one version more effective than the other for fat loss?
Both versions stimulate GH release, which supports fat metabolism. The pulsatile release from the no-DAC version may better mimic the GH pattern associated with fat oxidation during sleep. But both can support body composition goals when combined with proper diet and exercise.
Do I need Ipamorelin with both versions?
Adding Ipamorelin is recommended with both versions for a combined effect. The combination produces a greater GH response than either peptide alone. But each can be used as a standalone peptide if your provider recommends it.
What's Your Next Move?
You have the information. Now let a licensed provider help you put it into action. FormBlends makes it simple) answer a few questions and get a personalized recommendation.
Sources &. References
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 2006;91(12):4792-4797. Doi:10.1210/jc.2006-1702
Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.
Last updated: 2026-03-24
Ready when you are
CJC-1295 DAC
Long-acting GHRH analog with Drug Affinity Complex for sustained GH elevation · From $42/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
Learn about CJC-1295 DAC →